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Pneumococcal serotype identification is essential to monitor pneumococcal vaccine effec-
tiveness and serotype replacement. Serotyping by conventional serological methods are
costly, labour-intensive, and require significant technical expertise. We compared two differ-
ent molecular methods to serotype pneumococci isolated from the nasopharynx of South
African infants participating in a birth cohort study, the Drakenstein Child Health Study, in
an area with high 13-valent pneumococcal conjugate vaccine (PCV13) coverage.
Methods
A real-time multiplex PCR (rmPCR) assay detecting 21 different serotypes/-groups and a
sequetyping assay, based on the sequence of thewzh gene within the pneumococcal cap-
sular locus, were compared. Forty pneumococcal control isolates, with serotypes deter-
mined by the Quellung reaction, were tested. In addition, 135 pneumococcal isolates
obtained from the nasopharynx of healthy children were tested by both serotyping assays
and confirmed by Quellung testing. Discordant results were further investigated by whole
genome sequencing of four isolates.
Results
Of the 40 control isolates tested, 25 had a serotype covered by the rmPCR assay. These
were all correctly serotyped/-grouped. Sequetyping PCR failed in 7/40 (18%) isolates. For
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the remaining isolates, sequetyping assigned the correct serotype/-group to 29/33 (88%)
control isolates. Of the 132/135 (98%) nasopharyngeal pneumococcal isolates that could
be typed, 69/132 (52%) and 112/132 (85%) were assigned the correct serotype/-group by
rmPCR and sequetyping respectively. The serotypes of 63/132 (48%) isolates were not
included in the rmPCR panel. All except three isolates (serotype 25A and 38) were theoreti-
cally amplified and differentiated into the correct serotype/-group with some strains giving
ambigous results (serotype 13/20, 17F/33C, and 11A/D/1818F). Of the pneumococcal sero-
types detected in this study, 69/91 (76%) were not included in the current PCV13. The most
frequently identified serotypes were 11A, 13, 15B/15C, 16F and 10A.
Conclusion
The rmPCR assay performed well for the 21 serotypes/-groups included in the assay. How-
ever, in our study setting, a large proportion of serotypes were not detected by rmPCR. The
sequetyping assay performed well, but did misassign specific serotypes. It may be useful for
regions where vaccine serotypes are less common, however confirmatory testing is advisable.
Introduction
The pneumococcus (Streptococcus pneumoniae) is a common cause of invasive disease and
respiratory tract infections including bloodstream infections, meningitis, pneumonia and otitis
media [1–3]. Patients at risk include those at the extremes of age and the immunocompro-
mised, particularly those affected by cell-mediated immune deficiencies. Colonisation of the
nasopharynx with a homologous strain of pneumococci precedes the development of invasive
and respiratory tract disease [2,4,5]. Serotyping of the pneumococcal polysaccharide capsule,
the immunogenic component of current vaccines, remains the cornerstone of strain characteri-
zation. To date, more than 90 capsular serotypes have been described and new ones continue
to be described [6,7]. Multiple pneumococcal serotypes can colonize the nasopharynx succes-
sively over long period of time, or at any one time [8–10]. Invasive disease is commonly
regarded as resulting from a single serotype. Public health programs employ serotype preva-
lence data from invasive disease to assist vaccine selection. Regular surveillance is required, and
relies mostly on phenotypic serotyping methods, most notably the Quellung method developed
in 1902 [11]. The antiserum utilised in this assay is costly, methods employed are labour inten-
sive, and require significant technical expertise and experience.
More practical, higher throughput typing techniques are required for expanding public
health laboratory services in many areas of the world to support growing disease control pro-
grams and epidemiological surveillance. Emerging technologies include alternative culture-
based phenotypic methods such as latex agglutination, dot blot ELISA and microbead assays
[10,12,13]. While the newer phenotypic methods all have their distinct benefits and often sur-
pass Quellung in terms of rapidity and cost, some of the methods require sophisticated and
expensive instruments.
Promising genotypic typing methods that target serotype-specific regions of the cps genes
have been developed including multiplex Polymerase Chain Reaction (PCR) with subsequent
agarose gel electrophoresis [14–16]; restriction fragment length polymorphism (PCR-RFLP)
[17]; automated fluorescent capillary electrophoresis (FAF-mPCR) [18]; electrospray ioniza-
tion mass spectrometry (PCR/ESI-MS) [19]; reverse line blot hybridization assay (mPCR/RLB)
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[20] and real-time multiplex PCR (rmPCR) [21] including the recently described nanofluidic
rmPCR [22]. PCR with subsequent target detection is prone to amplicon contamination and is
more labour intensive than rmPCR. rmPCR obviates the need for amplicon manipulation, is
highly sensitive, fast and less labour intensive. PCR assays do not require viable isolates and
have the potential to detect multiple serotypes simultaneously [21,23–26]. More recently
sequetyping, a sequence-based typing method, has been described [27]. There are currently no
published head-to-head comparisons of the accuracy of the sequetyping vs. multiplex PCR
approaches. Given the heterogeneity and recombinogenic nature of pneumococci, capsular
typing tools which infer type from DNA sequence, including target enrichment-based next
generation sequencing (NGS) and whole genome sequencing (WGS) [28] are attractive newer
methods to complement the molecular typing methods discussed above and may also aid in
resolving discrepant phenotypic and genotypic findings.
Materials and Methods
Assay validation
Isolates comprised 40 Quellung-typed control strains, Fig 1, (kindly donated by Dr. Anne von
Gottberg, Centre for Respiratory Diseases and Meningitis (CRDM), National Institute for
Communicable Diseases (NICD), South Africa [29]). These isolates were transported on Dor-
set egg medium [30], subcultured onto Columbia blood agar base with 2% agar, 5% horse
blood and 4 μg/mL gentamicin media (CAG) upon receipt (Green point Media Laboratory of
the National Health Laboratory Service, Cape Town, South Africa) and incubated at 37°C in
5% CO2 overnight. The resulting colonies were inoculated into in 1 ml skim milk-tryptone-glu-
cose-glycerol (STGG) transport medium frozen at -80°C for batch processing.
Subsequently, 135 pneumococcal isolates (Fig 1) were cultured from nasopharyngeal (NP)
swabs that were collected from 83 healthy infants by employing nylon flocked swabs (Copan Ita-
lia, Brescia, Italy). Infants were recruited between May 2012 and September 2013 as part the
Drakenstein Child Health Study (DCHS), a South African birth cohort study [31]. NP swabs
were collected employing theWorld Health Organization protocol for pneumococcal carriage
studies. Briefly, the collected NP swabs were immediately placed into 1 ml STGG, transported
on ice to the laboratory and frozen at -80°C for batch processing. After thawing, STGG samples
were vortexed for 15 s before a 10 μl aliquot was inoculated onto Columbia blood agar base with
2% agar, 5% horse blood (BA) plates and incubated at 37°C in 5% CO2 overnight. Presumptive
pneumococcal isolates were identified by colony morphology, α-hemolysis and ethylhydrocu-
preine (optochin) disk susceptibility (Oxoid, Basingstoke, UK) as previously described [32–34].
Nucleic acid extraction
Prior to rmPCR and sequetyping, all isolates were subjected to nucleic acid extraction employ-
ing a heat lysis method as previously described [35]. Briefly, a sweep of pneumococcal colonies
was obtained from primary BA plates that were inoculated with thawed STGG aliquots con-
taining either pneumococcal control strains or carriage isolates. The colony sweeps were resus-
pended in 100 μl of phosphate-buffered saline, pH 7.4 (PBS; Sigma-Aldrich, St. Louis, MI)
thereafter heated at 95°C for 5 min. The supernatant containing genomic DNA (gDNA) was
ten-fold serially diluted in PBS before nucleic acid amplification.
Real-time multiplex PCR
The rmPCR, designed as a 7x3-plex that targets 21 serotypes. We used the multiplex scheme
for an African region, based on a relatively limited sample observed [21]. This assay targets all
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the pneumococcal serotypes included in PCV13 and 8 other additional serotypes/-groups
(PCV13 serotypes: 1, 3, 4, 5, 6A/6B, 7F/7A, 9V/9A, 14, 18C/18A/18B/18C, 19A, 19F, 23F, 23A;
The 8 additional serotypes/-groups include: 2, 6C/6D, 11A/11D, 12B/2F/46, 15A/15F, 16F,
22F, 33A/33F). Briefly, the PCR reaction comprised 12.5 μl of 2X SensiFAST Probe No-ROX
One-Step master mix (Bioline, Taunton, MA), primers and probes for serotype as described by
Pimenta et al, 5 μl gDNA (diluted 1:1000) and nuclease/RNase-free water (Applied Biosystems,
Irving, CA) for a final reaction volume of 25 μl (S1 Table). The thermal cycling conditions con-
sisted of initial denaturation at 95°C for 10 min, followed by 40 cycles of denaturation at 95°C
for 15 s and annealing/extension at 60°C for 1 min employing a CFX96 Touch Real-Time PCR
amplification system (Bio-Rad Laboratories, Hercules, CA)
Sequetyping
The assay was performed as previously described [27] with minor modification: the PCR reac-
tion comprised 12.5 μl of 2X KAPA Taq Ready Mix (KAPA Biosystems, Boston, MA), 1 μl of
primer mix, 2 μl gDNA (diluted 1:10), 8.5 μl nuclease/RNase-free H2O (Applied Biosystems) in
a final volume of 25 μl (S2 Table). Thermal cycling consisted of an initial denaturation at 95°C
for 5 min, followed by 30 cycles of denaturation at 95°C for 30 s, annealing at 65°C for 30 s,
Fig 1. Flow chart showing the pneumococcal isolates included in the study. *Of the 40 isolates that were tested by rmPCR, only 25 were included as
part of the rmPCR targets.
doi:10.1371/journal.pone.0137349.g001
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and extension at 72°C for 90 s employing an Applied Biosystems 2720 Thermal Cycler
(Applied Biosystems). The PCR products were separated by electrophoresis in 1.5% agarose gel
(SeaKem LE Agarose; Lonza, Rockland, ME) for 45 min at 80 V in a 1X Tris-acetate EDTA
buffer. Ethidium bromide-stained DNA products were visualized under UV illumination and
sized by using a 1–kb DNAmolecular size marker (HyperLadderv1-kb; Bioline).
PCR products were prepared for sequencing employing Exo-SAP IT (Affymetrix, Maumee,
OH) according to the manufacturer’s instructions. Prepared amplicons were submitted for
cycle sequencing employing the BigDye Sequence Terminator kit V3.1 (Applied Biosystems)
and analysed on an ABI 3500 XL Genetic Analyzer (Appplied Biosystems) by Inqaba Biotech
(Inqaba Biotechnical Industries [Pty] Ltd, Pretoria, South Africa). Sequencing was performed
in both directions using forward (cps1), 5’-GCA ATG CCA GAC AGT AAC CTC TAT-3’, and
reverse (cps2), 5’-CCT GCC TGC AAG TCT TGA TT-3’ primers.
DNA sequences obtained were assembled and edited using DNA Baser Sequence Assembler
v4 (www.DnaBaser.com). The consensus sequences were used to interrogate the GenBank data-
base (http://www.ncbi.nlm.nih.gov/blast/) and assign a serotype using the criteria as per proto-
col [27]. Briefly, the serotype of the wzh nucleotide sequence from GenBank with the highest
BLAST bit score was assigned, provided that sequence identity was>98% with the query ampli-
con nucleotide sequence. To automate the above process, a Java-based program, Sequetyper
(available at http://www.gematics.com/sequetyper.html) was developed and validated to auto-
matically analyse and determine the pneumococcal serotype based on interrogation of GenBank
with the input forward and reverse sequences of the generated wzh amplicon. This application
is suitable for high-throughput analysis of sequetyping data (S1 Fig).
Quellung testing
Pneumococcal control and nasopharyngeal isolates were submitted to CRDM for quellung test-
ing using specific anti-sera (Statens Serum Institut, Copenhagen, Denmark). Serotype 6C was
distinguished from serotype 6A by PCR [36], while serotype 25A and 38 were undistinguish-
able and hence reported as 25A/38 [37].
Next-generation sequencing
Three pneumococcal carriage isolates serotyped as 16F by Quellung and rmPCR but identified
as 9V by sequetyping were subjected to WGS. The 3 discordant isolates as well as a control
strain identified as 9V by Quellung, sequetyping and rmPCR were also included. Briefly,
gDNA was isolated with a Wizard Genomic DNA Purification Kit (Promega Corporation,
Fitchburg, WI) according to the manufacturer's instructions. The gDNA quality was assessed
using the Qubit Fluorometer (Life Technologies, Carlsbad, CA), the NanoDrop ND-1000 (Life
Technologies) and agarose gel electrophoresis used to determine absolute concentration, poly-
phenolic/polysaccharide/chaotropic salt contamination and gDNA integrity respectively.
Quantified gDNA was submitted to the Centre for Proteomics and Genomic Research (CPGR)
for WGS. Briefly, sequencing libraries were generated using the Nextera XT DNA Sample Prep
Kit (Illumina, San Diego, CA) and the libraries were indexed according to the dual-bar cording
protocol (with i7 and i5 primers) using the Nextera XT Index Kit (Illumina). Libraries were
then normalized, pooled, and a 5% PhiX control added before sequencing with the Illumina
MiSeq Reagent Kit v2 (500 cycle) on the Illumina MiSeq system.
De novo sequence assembly
The quality of the output sequence data was assessed using FastQC [38] and sequencing adapt-
ers were trimmed using Trimmomatic [39]. The 3'-end nucleotides with PHRED scores below
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20 were trimmed using the fastx_trimmer tool of FASTX toolkit (http://hannonlab.cshl.edu/
fastx_toolkit) [40]. The sequence data was then assembled de novo using SPAdes v3.0.0 assem-
bler [41]. Draft genome assemblies were annotated individually using RAST (Rapid Annota-
tion using Subsystem Technology) [42]. The contigs containing putative cps regions were
identified through the standalone blastall homology searches against the 16F (Accession:
CR931668) and 9v (Accession: CR931648) annotated reference genomes and then extracted to
a separate file using a shell command based on SAMtools [43]. These contigs were then aligned
and visual representation of the alignments was performed using the Artemis Comparison
Tool (ACT) v6 and WebACT [44].
Data analysis
Results of the two molecular serotyping assays up to the serogroup level were compared with
serotyping results obtained by Quellung testing. In cases of discordance between the two
molecular serotyping assays, the results were confirmed by Quellung testing. Serotype distribu-
tion was determined based on Quellung results. Where more than one isolate was tested from
the same child, isolates of the same serotype were included only once in the analysis.
Ethical consideration
Ethical approval was obtained from the Human Research Ethics Committee of the Faculty of
Health Sciences, University of Cape Town (HREC ref: 062/2011) and the Western Cape Pro-




Of the 40 pneumococcal control isolates subjected to rmPCR, 25 isolates yielded a positive sig-
nal; 15 isolates failed to yield detectable amplification signal. Of the 25 rmPCR positive isolates,
results were all (25/25) concordant with Quellung confirmed serotypes (Table 1).
Sequetyping
Of the 40 pneumococcal control isolates subjected to sequetyping, 33 isolates yielded single
amplicons of ~ 1,061 bp; 7 isolates failed to yield detectable amplicons. Sequence analysis
yielded 29/33 (88%) sequetype-Quellung concordant results (Table 1). Of the four discordant
results, Quellung 16F was identified as 9V by sequetyping, Quellung 46 was identified as 12A
by sequetyping while Quellung 18C was identified as 18B. The fourth discordant isolate yielded
no match (>98%) when submitted to GenBank and is considered novel (GenBank submission
accession number: BankIt1792036). The wzh PCR was negative in 7/40 (18%) control isolates
tested, which consequently could not be sequetyped. Detailed results are provided in Table 1.
Carriage isolates
Of 135 pneumococcal isolates tested, 132 (98%) were assigned a serotype/-group by the Quel-
lung reaction (Tables 2 and 3). Three (3) isolates could not be typed by either Quellung or
molecular methods. A total of 69 (52%) isolates were assigned a serotype covered by the rmPCR
assay. Of these, the rmPCR assay assigned the correct serotype to all 69 isolates (Tables 2 and 3).
Of the 135 pneumococcal nasopharyngeal isolates that were sequetyped, 125 isolates yielded
single amplicons of ~ 1,061 bp. A correct serotype/-group was determined in 112 (85%) of the 132
nasopharyngeal isolates. The partial wzh sequence of 2/3 Quellung 18C isolates did not match any
Pneumococcal Molecular Serotyping Methods
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Table 1. Concordance of molecular serotyping results of pneumococcal control strains.
Serotype rmPCRa Sequetyping
1 1 1







































armPCR: real-time Multiplex PCR.
N/A* = serotype not included in the rmPCR panel.
No ID b. = sequence identity of 98% with sequences in GenBank.
Negc = negative sequetyping PCR result.
dThe Sequetyping assay mistyped serotype 18C as 18B.
doi:10.1371/journal.pone.0137349.t001
Pneumococcal Molecular Serotyping Methods
PLOS ONE | DOI:10.1371/journal.pone.0137349 September 3, 2015 7 / 17
of the pneumococcal wzh sequences in GenBank with>98% identity while the third was deter-
mined as 18B. The wzh PCR was negative for seven isolates of which three were serotype 25A/38,
two were serotype 11A and two were serotype 19A, as confirmed by Quellung testing. Consistent
misidentifications by sequetyping, occurring in more than one isolate, were observed for serotype
16F (two isolates sequetyped as 9V) and for serotype 17F (two isolates sequetyped as 33C).
Fig 2 shows the serotype distribution of the pneumococcal isolates, excluding duplicate iso-
lates of the same serotype from the same infant. The most frequently identified serotypes were
11A (9 infants), 13 (8 infants), 15B, 15C (both 7 infants), 16F and 10A (both 6 infants). Of the
91 isolates (the total number of isolates when calculating each serotype only once per child), 22
(24%) were serotypes included in PCV13 while 69 (76%) serotypes were not.
Table 2. Carriage isolate serotypingmethod concordance.
Serotype (n)a rmPCR (n) b Sequetyping (n) Remarks
1 (1) 100% (1) 100% (1)
3 (1) 100% (1) 100% (1)
4 (1) 100% (1) 100% (1)
6A (2) 100% (2) 50% (1) 2 rmPCR as 6A/6B; 1 sequetyped as 9V
6B (11) 100% (11) 100% (11) 11 rmPCR as 6A/6B
6C (1) 100% (1) 100% (1) 1 rmPCR as 6C/6D; 1 sequetyped as 6C/6D
10A/11A (1) 100% (1) 100% (1) 1 rmPCR as 11A/11D; 1 sequetyped as 10A
11A (8) 100% (8) 75% (6) 8 rmPCR as 11A/11D; 6 sequetyped as 11A/11D/18F; 2 no amplicon in sequetyping
14 (5) 100% (5) 100% (5)
15A (10) 100% (10) 100% (10) 10 rmPCR as 15A/15F
16F (8) 100% (8) 63% (5) 3 sequetyped as 9V
17F/1¥ (2) 100% (2) 100% (2) 2 rmPCR as 1; 2 sequetyped as 1
18C (3) 100% (3) 33% (1) 3 rmPCR as 18A/18B/18C/18F; 1 sequetyped as 18B, 2 sequetyped with low identity score
19A (8) 100% (8) 75% (6) 2 no amplicon in sequetyping
19F (5) 100% (5) 100% (5)
22F (2) 100% (2) 100% (2) 2 rmPCR as 22A/22F; 2 sequetyped as 22A/22F
7C (1)* N/A 100% (1)
9N (4)* N/A 100% (4)
10A (8)* N/A 100% (8)
13 (14)* N/A 93% (13) 1 sequetyped as 15B; 13 sequetyped as 13/20
15B (7)* N/A 100% (7) 7 sequetyped as 15B/15C
15C (7)* N/A 100% (7) 7 sequetyped as 15B/15C
17F (3)* N/A 33% (1) 2 sequetyped as 33C
19B (2)* N/A 100% (2) 1 sequetyped as 19C, 1 sequetyped as 19F
21 (5)* N/A 100% (5)
25A/38 (3)*c N/A Negd 3 no amplicon in sequetyping
35A (9)* N/A 89% (8) 8 sequetyped as 33A/33F/35A, 1 sequetyped as 13/20
OMNI NEG (3) Neg Neg
Total (132) 69 112
aThe numbers in closed brackets indicate the correct identification of a Quellung-confirmed serotype by the rmPCR and sequetyping assays;
brmPCR: real-time multiplex PCR;
* = serotypes not included in rmPCR assay.
¥ Mixed serotypes detected;
Negd = negative sequetyping PCR result;
cSerotype 25A and 38 were undistinguishable by Quellung and hence reported as 25A/38 [37].
doi:10.1371/journal.pone.0137349.t002
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Next-generation sequencing
A total of 14.3 million paired-end sequence reads (2 x 250) were obtained for the four samples
as shown in Table 4. The quality control steps used preserved the sequence number though
reducing the sequence read length to 230 forward, and 120 reverse (230–120 fr) respectively.
Table 3. Summary of molecular serotyping results of pneumococcal nasopharyngeal isolates from healthy children compared with the serotype
determined by the Quellung reaction.
rmPCRa, correctly serotypedb Sequetyping, correctly serotypedb Total
Yes No Negativec Yes No Negativec
Quellung Typeable 69 0 63¥ 112 13 7 132
nontypeable 0 0 3 0 0 3 3
Total 69 0 66 112 13 10 135
a rmPCR: real-time multiplex PCR.
b isolates typed correctly to the serogroup level compared with phenotypic Quellung reaction results.
c Negative: no amplification.
¥ all serotypes not covered by the rmPCR panel.
doi:10.1371/journal.pone.0137349.t003
Fig 2. Serotype distribution of nasopharyngeal pneumococcal isolates. The figure includes serotypes detected from the Drakenstein Child Health
Study, determined by Quellung reaction, excluding duplicate serotypes from the same infant. Blue = serotypes included in PCV13; Red = serotypes not
included in PCV13. Green = non-typable isolates.
doi:10.1371/journal.pone.0137349.g002
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One of pneumococcal control strains and two DCHS strains were serotyped as 16F in Quel-
lung, but mistyped as 9V by sequetyping. A comparison of the cps gene loci showed that the
wzh sequence of all the three queried 16F strains was entirely 9V-like (Fig 3). This is in contrast
to the rest of their cps loci: which in terms of structural gene organization as well as specific
sequence of these genes were entirely 16F-like. Comparative genome analysis of the annotated
gene structure showed a marked clustering for the other three queried 16F serotypes and were
all significantly different from the 9V reference (Fig 4). MLST loci of these 16F strains showed
Table 4. NGS data and assembly metrics.
Isolate ID Paired sequence reads Number of contigs N50 (Kb) Draft genome size (Mb) Sequencing coverage
9v 1 688 340 52 57.1 2.1 144x
16f 4 621 214 47 68.1 2.1 368x
103347 2 226 252 62 77.3 2.1 184x
103385 5 773 884 56 82.3 2.1 437x
doi:10.1371/journal.pone.0137349.t004
Fig 3. Similarity of 16F-like capsular polysaccharide (cps) gene loci. Sequences from pneumococci serotyped as 16F Quellung but sequetyped as 9V
was compared to reference 9V (CR931648) and 16F (CR931668) cps sequences. Artemis Comparison Tool (ACT) was used to generate and view gene
homology. The top lines represent the forward and reverse strand of a serotype 9v reference, the middle lines represent the queried 16F strain and the
bottom lines shows the 16F reference. The portion of thewzh gene that is amplified by the sequetyping assay is shown by the blue rectangle. The clear
blocks below the blue box shows regions were the genes that are not similar. BLASTNmatches are shown as red bands between sequences, indicating the
degree of similarity between the sequences.
doi:10.1371/journal.pone.0137349.g003
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a shared a 16F-like-MLST-type, except the third strain (103385) which had a unique glutamate
dehydrogenase gene (gdh) allele.
Discussion
To identify a rapid high throughput molecular serotyping assay, rmPCR was compared to
sequetyping, in the first place using a panel of 40 control isolates. rmPCR is designed to detect
and identify 21 serotypes including all serotypes/-groups in PCV13, all of which were included
in our analysis. Concordance with Quellung was 100% (25/25) for those control isolates
included in the rmPCR panel. Sequetyping is designed to identify up to 46 different serotypes/-
groups, concordance with Quellung for the 40 control strains was 88% (29/33), with failure of
sequetyping PCR for 7 strains.
Amongst the pneumococcal carriage isolates tested, the correct serotype/-group could be
assigned to 52% (69/132) and 85% (112/132) by rmPCR and sequetyping respectively. Of these,
Fig 4. Comparative genome analysis of pneumococcal serotypes 16F and 9V genetic background.When the sequence identities of all four genomes
were compared using RAST(Rapid Annotation using Subsystem Technology), the genome backbone of all three 16F (103347 and 103385 from this study
and a 16F control strain) were mostly identical but divergent from 9V. The colour codes represent how close or divergent the genomes are. Therefore, similar
genome backgrounds will have similar colours.
doi:10.1371/journal.pone.0137349.g004
Pneumococcal Molecular Serotyping Methods
PLOS ONE | DOI:10.1371/journal.pone.0137349 September 3, 2015 11 / 17
63/132 isolates were not included in the rmPCR panel. However, the sequetyping assay was theo-
retically expected to amplify and differentiate all except three isolates (Serotypes 25A and 38)
into the correct serotype/-group with some strains giving ambiguous results (serotype 13/20,
17F/33C, and 11A/D/1818F). For those serotypes included in the rmPCR assay, there was good
agreement between the results across all three assays. The high number of negative results from
rmPCR amongst nasopharyngeal isolates was not surprising since this assay is likely to be less
useful in areas where pneumococcal conjugate vaccines have been implemented resulting in sero-
type replacement which may arise as a result of either serotype unmasking or capsular switching.
Data from the United States on invasive pneumococcal isolates showed a decline in serotypes
included in the rmPCR assay from 92% (3812/4106) prior to PCV7 implementation to 79%
(2939/3708) after PCV7 roll out and a further decrease to 74% (2581/3480) post PCV13 imple-
mentation (Unpublished US Active Bacterial Core surveillance data). Amongst our small cohort,
non-vaccine serotypes 11A, 13, 15B, 15C, 16F and 10A were the most prevalent serotypes identi-
fied. Similarly, data from a number of other post PCV13 surveillance studies have reported sero-
types 11A, 15A/B/C, 16, but also 22F, 21 and 34 as prevalent non-vaccine serotypes [45–51]. The
original rmPCR protocol [21] did not make reference to any internal control in the assay set up.
However, as part of our assay set-up and validation, we screened all the samples with a 16S rRNA
PCR to check for inhibition and subjected all rmPCR negative samples to cpsA PCR to check the
integrity of the capsulation locus, although not applicable for serotypes 14, 25, 35A and 38 [52].
The broad range of serotypes that are theoretically detectable by sequetyping is a major
advantage of this technique. It is not clear why, in this study, amplification failed for 7/40
(18%) control strains. Interrogation of published gene sequences for these serotypes indicated
that these serotypes should generate PCR products with the protocol used here [27]. PCR inhi-
bition was excluded based on successful lytA PCR in all 7 strains. Interestingly, four of the
nasopharyngeal cariage isolates that failed to amplify during sequetyping were serotypes for
which a similar problem was encountered when sequetyping the control isolates (serotypes
11A and 19A). The remaining three sequetype-negative isolates were of serotype 25A/38 which
were expected to be non-amplifiable because of absence of the reverse primer binding site in
the wzd gene [6,27,53]. Sequetyping misidentified three control strains (for which Quellung
and rmPCR were concordant). The sequence obtained from wzh amplicon of serotype 2 did
not match any of the sequences in GenBank with>98% sequence identity. The original study
describing sequetyping did not test this serotype although their insilico analysis had predicted
that the primer sets should be able to amplify serotype 2 [27]. Misidentification of the serotype
46 isolate as 12A is explained by high relatedness between these serotypes as their cps gene clus-
ters are almost identical [6]. Based on our observation of mistyping the 18C PCV13 serotype as
18B by sequetyping, it may be warranted to confirm all 18B results by Quellung. Misidentifica-
tion of 17F isolates as 33C was predicted by the original sequetyping paper as these serotypes
cannot be distinguished based on their wzh sequence [27].
We found one control strain and three nasopharyngeal strains that were serotyped as 16F
by Quellung, but sequetyped as 9V. Even though the wzh sequences of the queried 16F was
entirely 9V-like, the serotype specific wzy/wzx genes are entirely 16F-like. Based on analysis of
the core genome, the 16F control strain was identified as sequence type (ST) 5326, one of the
nasopharyngeal isolates was identified as ST4088, while the other nasopharyngeal isolates was
a new ST, which was a single-locus variant of ST5326. These sequence types are all commonly
associated with serotype 16F [44]. Therefore, our strains seem to be 16F strains in almost every
sense, they only have a 9V-wzh gene. This structural difference is not expected to have occurred
as a result of vaccination, because none of the currently used vaccine formulations include
serotype 16F and the exchanged 9V gene does not result in a modified phenotype. In practice,
in our setting, each isolate with a 9V sequetype result should be investigated further.
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Both molecular assays are able to type many pneumococcal strains only to the serogroup
level. Discrimination of individual serotypes within a serogroup may be important for more
detailed assessment of carriage and vaccine effectiveness. When selecting a serotyping method,
test characteristics other than accuracy may also be relevant. The sequetyping assay, which
involves a single amplification step, is inexpensive compared with the rmPCR assay, which is
labour intensive, includes many costly PCR probes and is constrained by the limited multiplex-
ing options of real-time PCR. Interpretation of the sequetyping results is based on the publi-
cally available GenBank database. An advantage of this is its free accessibility, but the
uncontrolled and changing nature of this database could be a risk for the assignment of sero-
types. Our automated ‘sequetyper’ application makes analysis of the relevant sequence data for
sequetyping rapid and simple. A significant disadvantage of sequetyping is that the targeted
wzh gene is not serotype-specific and does itself not determine serotype—the results are
inferred based on association. It is entirely feasible therefore (as we found here) that for specific
serotypes and in particular populations of pneumococci that this association may not correctly
predict serotype. The technique is therefore likely only useful for typing pneumococci from
populations of pneumococci where such association has been confirmed using another typing
technique. In our case this would mean confirming serotype for a smaller subset such as sero-
type 9V, 13, 20 and serogroup 33. The CDC Streptococcal laboratory has recently provided an
update of a conventional multiplex PCR assay (not available at the time of this study) that uti-
lises 41 serotype-specific primer sets to detect upto 70 different pneumococcal serotypes
(http://www.cdc.gov/streplab/downloads/pcr-oligonucleotide-primers.pdf). The basis/method-
ology for this assay is similar to the rmPCR employed here although less costly. The benefits of
deducing more than 70 serotypes by this assay needs to be weighed against sensitivity and risk
of amplicon contamination.
In conclusion, sequetyping is a useful technique for large scale molecular serotyping of
pneumococcal strains, particularly post-PCV introduction, because of the broad range of non-
vaccine serotypes that can be detected, low cost and ease of use. Our results suggest the need
for an extended and carefully curated database of serotype-specific sequence data, which will
increase the accuracy and expand the serotype coverage of the sequetyping method. However,
given the potential for gene exchange that could result in false assignment of serotype by seque-
typing, it is necessary to confirm serotype assignment using a different method. This may still
be cost-saving as it would involve, for example, testing only the specific serotype assigned by
serotyping, using the Quellung method, in most instances. The rmPCR assay, ideally extended
to include more serotypes is reliable but cost, time required to perform testing, and currently
restricted serotype coverage may limit its widespread application for large epidemiological
studies. In the future it is likely that WGS will be increasingly used as a tool for serotype infer-
ence. WGS has many advantages, in that additional information (such as multi-locus sequence
type and antimicrobial resistance) can be inferred from the same dataset without additional
testing, and that serotype can be definitively assigned. As sequence costs decline further, bioin-
formatic pipelines are increasingly automated and the technology is more widely available in
low-resource settings it is likely that WGS will replace conventional typing tools for
pneumococci.
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